87% of respondents deemed mRNA a key modality for the future More than 60% vaccine makers surveyed plan revamp or new facilities for mRNA manufacturing to meet demand Skilled personnel, tech-transfer expertise, reliable supply chain, and regulatory guidelines critical to new technology adoption According
Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the launch of the Medtronic Open Innovation Platform (OIP) for APAC. The OIP will bring strategic collaboration in healthcare technologies from various innovators across the Asia-Pacific and several stakeholders across the healthcare ecosystem through
